Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3.
| Image |  |
|---|---|
| Description | scientific article published on 21 January 2014 |
| Author/s |
author: David Piwnica-Worms |
| Publication date | January 21, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |